US3875012A - Apparatus and method for the detection of microbial pathogens - Google Patents

Apparatus and method for the detection of microbial pathogens Download PDF

Info

Publication number
US3875012A
US3875012A US437890A US43789074A US3875012A US 3875012 A US3875012 A US 3875012A US 437890 A US437890 A US 437890A US 43789074 A US43789074 A US 43789074A US 3875012 A US3875012 A US 3875012A
Authority
US
United States
Prior art keywords
centrifugation
aqueous
fluid
solution
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US437890A
Other languages
English (en)
Inventor
Gordon L Dorn
Joseph M Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
J K AND SUSIE L WADLEY RESEARCH INSTITUTE AND BLOOD BANK
Wadley Res Inst & Blood Bank
Original Assignee
Wadley Res Inst & Blood Bank
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wadley Res Inst & Blood Bank filed Critical Wadley Res Inst & Blood Bank
Priority to US437890A priority Critical patent/US3875012A/en
Priority to CA206,919A priority patent/CA1036055A/en
Priority to GB3693374A priority patent/GB1475015A/en
Priority to IT53444/74A priority patent/IT1029614B/it
Priority to AU75119/74A priority patent/AU496227B2/en
Priority to DE2455981A priority patent/DE2455981C2/de
Priority to FR7441736A priority patent/FR2264593B1/fr
Priority to JP50011968A priority patent/JPS5812061B2/ja
Application granted granted Critical
Publication of US3875012A publication Critical patent/US3875012A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082—Test tubes per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S215/00—Bottles and jars
    • Y10S215/03—Medical

Definitions

  • ABSTRACT An apparatus for the isolation and concentration of microbial pathogens from a sample fluid which comprises an elongated enclosed centrifugation receptacle containing an evacuated space in contact with a sterile aqueous solution of a material having a greater density than the sample fluid but able to selectively receive microbial pathogens from the sample fluid, a first injectable closure on one end thereof and a second injectable closure on its other end, and a sterile end chamber in communication with the second injectable closure which contains a sample fluid treating solution together with an injection needle assembly which when actuated will pass through the second injectable closure means and allow communication between the chamber and the evacuated space within the centrifugation receptacle to thereby allow the treating fluid to flow from the chamber into the evacuated space.
  • the sample fluid can be injected into the evacuated chamber of the centrifugation tube through a needle passing through the first injectable closure and allow the sample fluid to admix with the pretreating solution in the evacuated chamber.
  • the article is then subjected to centrifugation to allow the microbial pathogens to selectively pass into the liquid filter medium.
  • FIG. 1 A first figure.
  • This invention relates to the detection of microbial pathogens.
  • this invention relates to a novel apparatus which is used for admixing a sample fluid containing microbial pathogens with a treating fluid and thereafter selectively extracting the microorganisms from the sample fluid.
  • this invention relates to a novel method and apparatus for diagnosing septicemia.
  • Scpticemia which is the presence of pathogenic microorganisms in the blood, is one of the most serious types of infection encountered. in spite of an armament of antibiotics and fungal drugs, the mortality rate from septicemia is approximately 2571. ln addition, when shock accompanies septicemia, the mortality rate increases to over 60%. Patients who are suffering from debilitating diseases, undergoing major surgery, receiving immunosuppressive drugs. or anticancer medications are particularly prone to septicemia.
  • the liquid filter medium has a density greater than the sample fluid and comprises a sterile aqueous solution which will selectively receive microbial pathogens from the sample fluid. Thereafter, the confined sterile zone is subjected to centrifugation to force the sample fluid against the liquid filter medium and cause microbial pathogens to selectively pass therein and thereby separate from the mass of the body fluid sample. Next, the
  • liquid filter medium containing the microbial pathogens is separated from the remainder of the sample fluid and portions of the liquid filter medium are subjected to culturing conditions.
  • the improved method described above does provide a very rapid and efficient procedure for separating microbial pathogens from a sample fluid.
  • the sample fluid is admixed with lysing and anticoagulant agents prior to the time that it is injected into the evacuated centrifugation zone containing the liquid filter medium.
  • Some liquid filter mediums are incompatible with some of the pretreating and/or lysing agents. lt has not heretofore been possible to combine the two materials for long periods in the sterilized centrifugation tube. Therefore, it has been necessary to subject the sample fluid to the possibility of external contamination by the additional mixing step which of course means an additional entry into the closed system.
  • an apparatus for use in the improved method described above which will aseptically introduce the lysing agent into the evacuated centrifugation tube containing the liquid filter medium and thereby allow the blood sample or sample fluid to admix therewith just prior to the centrifugation step wherein the microbial pathogens are selectively removed from the remainder of the sample fluid by the liquid filter medium.
  • the improved apparatus of the subject invention generally comprises an elongated centrifugation tube containing an evacuated centrifugation chamber having a first end and a second end; a first injectable closure means sealably closing the first end thereof and a second injectable closure means sealably closing the second end thereof; and an enclosed end chamber containing a treating fluid such as a lysing agent is affixed on the second end of said elongated centrifugation vessel in communication with said second injectable closure means, said end chamber containing an injection means to aseptically transfer said treatment fluid from said end chamber chamber through said second injectablc closure means to said centrifugation chamber.
  • a treating fluid such as a lysing agent
  • said injection means comprises a tubular stylus positioned for reciprocal movement in said end chamber and has a first opening adjacent its leading end and a second opening in its barrel such that when advanced toward said second injectable closure means in said chamber, the stylus will pass through the second injcctable closure means and its first opening will communicate with the evacuated space while its second opening maintains communication with said end chamber; and means to actuate said stylus means.
  • the chamber containing the evacuated space also contains an aqueous filter medium having a greater density than the sample fluid and which will selectively receive the microbial pathogens from the sample fluid
  • the end chamber contains an aqueous solution of a lysing agent such as purified saponin extract and optionally other materials such as an anticoagulant and/or an oxygen scavenger such as ascorbic acid and/or a thioglycolate. It is preferred that such materials be sufficiently stable so that they will not decompose or be otherwise deleteriously affected under autoclaving conditions.
  • the above-described centrifugation and mixing apparatus is provided with a syringe means for removing the aqueous filter solution from the evacuated chamber which includes a stylus sufficiently long to only penetrate the thickness of the first injectible closure means and not to materially pass into said aqueous filter medium.
  • FIG. 1 is a sectional view of a preferred centrifugation and mixing apparatus of the subject invention
  • FIG. 2 is a sectional view of the apparatus of FIG. 1 showing the stylus in the upper chamber in actuated position;
  • FIG. 3 is a sectional view of the apparatus in FIG. 1 showing a sample fluid being injected therein through the bottom closure:
  • FIG. 4 is a sectional view of the apparatus of FIG. 3 showing the aqueous filter medium being removed via a needle passing through the lower closure;
  • FIG. 5 is a sectional view of another embodiment of the subject invention.
  • FIG. 6 is a sectional view of the embodiment of FIG.
  • the improved centrifugation and mixing apparatus of the subject invention provides an improved means for carrying out the method of detecting microbial pathogens which is set forth in copending patent application Ser. No. 428,135 filed Jan. 9, I974, (Attorneys docket No. B2532C) which is a continuation-in-part of US Pat. application Ser. No. 33l ,693, filed Feb. 12, I973, and such disclosure is herein incorporated by reference into the subject application.
  • the mixing and centrifugation apparatus 10 comprises an elongated, tubular centrifugation vessel 12, having an injectable closure member 14 which sealably closes the lower end thereof, and an injectable closure member 16 which sealably closes the upper end thereof. Furthermore, the upper end of injeetable closure member 16 is enclosed by cap 18. As shown, cap 18 carries screw threads 20 which operatively engage screw threads 22 positioned around the upper periphery of centrifugation vessel 12.
  • Cap 18 generally comprises a cylindrical body carrying screw threads 20 on the inside periphery of the opening thereof adjacent shoulder 24 which receives the outer rim ofinjectable closure member 16. Furthermore, the outer edge of shoulder 24 forms the opening of cavity 26, which is preferably a short cylindrical shape. The upper end of cavity 26 is enclosed by end wall 28. Rod 30 of push button member 32 extends through aperture 33 in end wall 28. Furthermore, rod 30 carries tubular stylus 34 on its leading end. Tubular stylus 34 comprises a sharp, beveled end 36 and an aperture 38 through its side wall as shown in the drawing. Furthermore, a resilient washer is positioned snugly around the upper end of tubular stylus 34 in a manner to seal the interior of cavity 26 above aperture 38 of tubular stylus 34.
  • Centrifugal vessel 12 can be made of glass or hard plastic such as polycarbonate or polypropylene and cap 18 can be made of a hard plastic.
  • Injectible closure member 14 can comprise a rubber'self-scaling stopper.
  • the leading end of injectable closure member 14 carries a frustoconical recess 14a.
  • Injectable web 14h forms the bottom of the frusto-conical recess 14a.
  • jectable closure member 16 can also comprise an injectable rubber self-sealing stopper.
  • the top of injectable closure member 16 carries a recess 16a, and the leading end of injectable closure member 16 carries a recess 16b. Recesses 16a and 16b are separated by injectable web 16c.
  • injectable closure members 14 and 16 can be of the same basic configuration. It is only desirable that in jectable closure member 16 carry recess 16a on its top portion and that injcctable closure member 14 carry a frusto conical recess 14a within the leading end thereof.
  • the sterile contents of centrifugation vessel 12 comprises liquid filter medium 42 and an evacuated space 44 which may be a complete or a partial vacuum.
  • Space 44 is maintained at a lower than atmospheric pressure at a predetermined value so that the centrifugation vessel can receive a known amount of liquid by injection through injectable closure members 14 and 16 without excessive pressure being built up within the interior thereof which could cause injectable closure members 14 and 16 to become dislodged from the openings within centrifugation vessel [2.
  • the liquid filter medium 42 can be of any of the liquid filter media set forth in said copending patent application for detecting microbial pathogens and generally, comprises an aqueous solution of any solute which is nontoxic to the microbial organisms being suspended,'
  • the liquid filter medium has a density greater than blood, e.g., greater than about 1.06 gm/cc, and will suspend blood cells or blood cell debris, but yet will receive microbial pathogens.
  • the liquid filter medium preferably contains a minor amount of a thermally sensitive gelling agent.
  • Suitable solutes which can be used in the liquid filter medium 42 include the sugars such as sucrose, glucose, maltose, fructose, manitol, sorbitol, and the like.
  • liquid filter medium 42 should be at least about 40 wt 7( of the sugar and can contain the sugar up until the saturation limit thereof.
  • the sugars are contained within liquid filter medium 42 in the range of from about 50 wt 71 thereof.
  • the sugars, and especially sucrose are preferred solutes for liquid filter medium 42 because the liquid filter medium can be maintained at a physiological pH, i.e., 6.0-7.0 and when combined with gelatin, they can be autoclaved.
  • any solute can be used in the scope of this invention so long as the resulting solution is more dense than red blood cells and red blood cell debris, and is nontoxic to the microbial pathogens.
  • suitable such materials include a chemical commonly known as Hypaque sodium, C H I N NaO (3,5 -diacetamido-2,4,6- triidobenzoic acid sodium salt). This material can be utilized in aqueous solution in the same concentration as the sugar as described above.
  • An example of a suitable such macromolecular solute is a water soluble crosslinked polymer having microporous openings throughout its solubilized network.
  • a suitable such water soluble polymer includes a copolymer of sucrose and epichlorohydrin which has a weight average molecular weight in the range of from about 300.000 to about 500.000, and an intrinsic viscosity of about 0.1 7dl/g, a specific rotation lal of +56.5 and contains dialyzable material in an amount of less than 1 weight percent.
  • a suitable such polymer is sold under the trademark of FICOLL by Pharmacia Fine Chemicals, Inc. 800 Centennial Avenue, Piscastaway, NJ.
  • dextran Another such polymer which can be used in the scope of this invention is dextran, having a weight average molecular weight in the range of about 10,000 to about 2,000,000 and preferably about 50,000
  • These polymers when dissolved in water in accordance with the subject invention function as a liquid filter medium for microbial pathogens and apparently have microporous openings throughout the solubilized network in the range of from about 1 micron to about 7 microns.
  • the water soluble polymer or macromolecular solute is preferably present in the aqueous solution in the range of from about 10 to about 40 wt "/2 and more preferably from about to about wt 7r thereof.
  • thermally sensitive gelling agent is meant any agent which will gel the aqueous solution of filter medium 42 at a temperature generally lower than room temperature but yet will liquefy at higher temperatures which are nondeleterious to the microbial pathogens. c.g., lower than about 50C and generally no higher than about 42C.
  • Suitable thermosensitive gelling agents include any such gelling agent which is nondeleterious to the solution or to the sample being analyzed. Examples of suitable such materials include gelatins, i.e., the proteins obtained from collagen by boiling skin, ligaments, tendons, bones, and the like in water. Any suitable amount of thermally sensitive gelling agent can be utilized, e.g., about 0.5 to about 5 wt Z of filter medium 42.
  • cavity 26 can be any convenient shape and preferably has a round cross sectional area and is a short cylindrical shape and is generally in alignment with recess 16a ofinjectable closure member 16.
  • tubular stylus 34 which is carried by rod 30 of push button member 32 will axially move within cavity 26, and resilient washer will maintain the upper portion of cavity 26 sealed at a point above aperture 38 of tubular stylus 34.
  • the spacing between aperture 38 and beveled end 36 of tubular stylus 34 is slightly greater than the thickness of injectable web 16c such that when push button 32 is fully extended, the opening adjacent beveled and 36 will pass through injectable web I6c and be positioned within space 44 ofcentrifugation vessel 12 while aperture 38 will communicate with cavity 26 as illustrated in FIG.
  • tubular stylus 34 will allow liquid 46 which is contained within or carried by recess 16a to pass into centrifugation vessel 12 by action of the lower pressure within space 44 and pass via aperture 38, the tubular body of stylus 34 and opening adjacent bevel point 16a.
  • Treating solution 46 can contain any suitable ingredient or ingredients with which it is desired to treat the sample fluid before microbial pathogens are separated therefrom.
  • treating solution 46 comprises an aqueous solution of a lysing agent for blood. Any suitable lysing agent can be utilized in the aqueous solution which is nontoxic to microorganisms.
  • a suitable such lysing agent is a nontoxic aqueous solution of saponin. It must be noted that many saponins are thought to be toxic to microbial pathogens.
  • the toxic saponin material can be detoxified in accordance with the invention set forth in this copending patent application and the resulting purified material used in the scope of this invention.
  • saponin preparations are nontoxic, and of course, the materials can also be used in the scope of the subject invention.
  • the aqueous solution can contain an anticoagulant and/or an oxygen scavenger.
  • a preferred anticoagulant is sodium polyanethol sulfonate (SP8) or Heparin, for exmaple.
  • SP8 sodium polyanethol sulfonate
  • Heparin for exmaple.
  • Sodium polyanethol sulfonate is preferred because it not only acts as an anticoagulant but also inhibits the phagocytic activity of granulocytes and monocytes and the normal antibacterial activity of serum.
  • Liquid filter medium 42 can comprise l.5 ml of an aqueous solution containing 50 wt '71 sucrose and 1.5 wt gelatin, for example.
  • Treating solution 46 can contain any such suitable constituent such as a lysing agent and/or an anticoagulant and/or an oxygen scavenger in any desirable concentration. Any amount of an anticoagulant which is sufficient for the amount of blood sample and any amount of lysing agent sufficient to lyse this blood sample, can be used, for example, 0.3 milliliters of an aqueous solution containing about 12% by weight of nontoxic saponin and about 2% by weight sodium polyanethol sulfonate. Initially, the centrifugation and mixing apparatus 10 is placed in an upright position as illustrated in FIG. 1 to allow liquid filter medium 42 to pass downwardly against injectable closure member 14. Next.
  • apparatus 10 is placed in a suitable cooling unit such as a refrigerator and chilled sufficiently to cause the gelatin to solidify the liquid filter medium 42.
  • a suitable cooling unit such as a refrigerator and chilled sufficiently to cause the gelatin to solidify the liquid filter medium 42.
  • the tube can be chilled to 49C.
  • push button member 32 is depressed in a manner illustrated in FIG. 2 to thereby force beveled end 36 of tubular stylus 34 through injectable web such that the opening adjacent beveled end 36 communicates with evacuated space 44 and aperture 38 remains in communication with cavity 26.
  • This action will subject the interior of cavity 26 to the lower pressure maintained within evacuated space 44 and this will therefore result in treating solution 46 passing through aperture 38, the barrel of tubular stylus 34, and from the opening adjacent the beveled end 36 into evacuated space 44 and become deposited as layer 46a upon the solidified liquid filter medium 42.
  • a sample fluid such as a blood sample (e.g., 8 ml) is obtained within syringe 50 which carries hypodermic needle 52.
  • the blood sample is then injected within the interior of centrifugation vessel 12 in a manner schematically illustrated in FIG. 3.
  • Needle 52 pierces web 14b of injectable closure member 14, passes through the congealed aqueous liquid filter medium 42 and then the plunger of syringe 50. is depressed to deposit blood sample on the congealed liquid filter medium 42 and cause a turbulent mixing with treating solution 46 and form a resulting mixture 48.
  • solution 46 can be added to the blood sample after it has been injected into centrifugation vessel 12; however, it is preferred that it be added initially to promote better mixing with the blood sample.
  • the turbulence caused by the blood passing into the evacuated space 44 and turbulently admixing with treating solution 46 will not disturb the liquid filter medium 42 which will remain as a solid bottom layer, as illustrated in FIG. 3.
  • cap 18 can be unscrewed and removed from the upper portion of apparatus 10 as illustrated in FIG. 4.
  • the mixing of the blood sample with the treating solution 46 containing the lysing agent will result in the red blood cells becoming lysed which will therefore minimize the possible trapping effect or erythrocytes and/or lymphocytes.
  • This trapping effect would in general comprise the erythrocytes or lymphocytes becoming stacked on top of the liquid filter medium during the centrifugation step and the stacked cells trapping microbial pathogens as they are passed downwardly during centrifugation and thereby .prevent them for reaching the liquid filter medium.
  • the sodium polyanethol sulfonate within treating solution 46 acts as an anticoagulate and inhibits the phagocytic activity of granulocytes and monoeytes and the normal antibacterial activity of the serum once it becomes admixed with the blood sample.
  • hypodermic needle 52 is withdrawn from the injcctablc closure member I4 and centrifugation vessel 12 containing the congealed liquid filter medium 42 and the blood sample admixed with treating solution 46 (illustrated as layer 48 in FIG. 3) is heated while in the upright position sufficiently to melt the gelatin and cause the liquid filter medium 42 to liquefy.
  • Centrifugation vessel 12 is heated to a temperature which will not destroy any microbial pathogens which may be present in the blood sample but which will be sufficient to liquefy the gelatin.
  • centrifugation vessel 12 can be heated by immersion in a water bath to a temperature set at about 37C-42C.
  • the separation of the microbial pathogens from the remaining portion of the blood sample is accomplished by placing centrifugation vessel I2 into a suitable centrifugation apparatus and subjecting it to sufficient centrifugal force to separate the microbial pathogens from the remaining constituents in the blood sample.
  • the speed and time of centrifugation can vary widely depending upon the construction material of centrifugation vessel 12 and the type of centrifugation apparatus.
  • the centrifugation can be conveniently accomplished by imparting between about 100 and about 6,000 gravities and preferably from about 1400 to 5000 gravities to centrifugation vessel 12.
  • a suitable method would include a swinging bucket centrifuge rotor which imparts between 2000 and 4000 gravities for 10 to minutes to the particular system described in this preferred embodiment.
  • a sterile syringe 54 carrying a shortened hypodermic needle 56 is passed through injectable web 14b of injcctable closure member 14 as illustrated in FIG. 4.
  • hypodermic needle 56 carries a stop 56a which will only allow the needle to pierce injectable web 14/; and the beveled end 36 to extend into liquid filter medium 42.
  • syringe 54 withdraws liquid filter medium 42 from the interior of centrifugation vessel 12 to leave the residual sample solution mixture 48 therewithin.
  • hypodermic needle can be utilized with syringe 54 and the needle can be passed to the interior of centrifugation vessel 12 to a point slightly past the interface between liquid filter medium 42 and the sample fluid layer 48 and the sample fluid layer initially removed from the tube.
  • the syringe should initially have the plunger retracted and be filled with sterile air in order that the sterile air can be pumped into the interior of centrifugation vessel 12 incrementally as the sample layer is displaced. Thereafter, the liquid filter medium 42 can be removed.
  • liquid filter medium 42 results in the liquid filter medium and the microbial pathogens becoming thoroughly admixed and generally uniformly distributed therein.
  • This liquid filter medium 42 containing the dispersed microbial pathogens is then distributed on suitable bacterial growth media. Suitable such growth media are set forth in said copending patent application entitled DETECTION OF MICROBIAL PATHOGENS.
  • one blood agar plate can receive 0.2 milliliters of the medium and the plate can be incubated at 37C in an aerobic atmosphere.
  • Another blood agar plate can receive 0.2 milliliters of the aqueous solution and can be incubated at 37C in a candle jar.
  • Another blood agar plate can receive 0.2 milliters of the aqueous solution and can be incubated at 37C in an anaerobic environment.
  • Another 0.2 milliliters of the solution can be placed on a sabouraud agar plate and incubated at 25C in an aerobic environment.
  • Another 0.2 milliliters of the solution can be placed on a EMB plate (Eosin methylene blue dye) plate and incubated at 37C in a candle jar.
  • Another 0.5 milliliters of the solution can be placed in a liquid thioglycolate medium and incubated at 37C.
  • the growth media can be checked daily for the presence of colonies.
  • the number of microbial pathogens in l milliliter of blood can be determined by multiplying the number of colonies by a correction factor. This correction factor takes into consideration the recovery rate for a given organism, the volumes of blood and liquid filter solutions employed and the amount of final mixture plated. In the general example set forth above. the correction factor is 1.56.
  • centrifugation and mixing apparatus 10 which shows another embodiment of the subject invention.
  • centrifugation apparatus 10 is exactly the same as upparatus 10 except for cap 70.
  • cap comprises an enclosed cylindrical cap member having screw threads 72 on the inside walls thereof. and a tubular stylus 74 rigidly attached to the end wall 75 thereof.
  • Tubular stylus 74 comprises the same basic configuration as tubular stylus 34 and comprises a beveled leading end 76 which carries an aperture and a second aperture 78 adjacent its midportion. As shown, with cap 70 in its first position as illustrated in FIG.
  • the beveled end 76 oftubular stylus 74 is positioned within treating solution 46 maintained within recess 16a of injectable closure member 16. in this position. It is preferred that a plastic strip 80 be positioned around the lower outside lip of cap 70.
  • Plastic strip 80 can comprise a thermoplastic or thermosctting material which will deform such as by heat to conform to the lower outside lip of cap 70 and lower outside screw threads 22 carried by centrifugation vessel 12. This will assure that the closure member 70 will be maintained in its first position illustrated in FIG. 5 during storage and handling.
  • cap 70 is then screwed downwardly to thereby deform strip 80 and force the beveled end 76 of tubular stylus 74 through the injectable closure member 16 as illustrated in FIG. 6. This will thereby allow communication between the cavity formed between recess 16a of injcctablc closure member 16 and end wall 75 and the evacuated space 44 and thereby cause treating fluid 46 to pass through aperture 78 through tubular stylus 74 and into the interior of centrifugation vessel 12.
  • An apparatus used for the isolation and concentration of microbial pathogens from a sample fluid comprising:
  • an enclosed centrifugation receptacle having a first end and a second end and containing an evacuated space maintained at a lower than atmospheric pressure adjacent a sterile aqueous solution of a material which is non-toxie to said microbial pathogens and has a greater density than the sample fluid but able to selectively receive microbial pathogens from said sample fluid and also containing a minor effective amount of a thermally sensitive gelling agent:
  • first injectable closure means sealably closing said first end of said elongated eentrifugation receptacle:
  • second injectahle closure means sealably closing the second end ofsaid elongated centrifugation receptacle
  • a scaled end chamber in alignment with said second injectable closure means on said second end of said elongated centrifugation receptacle and containing a sample treating fluid sealed therewithin;
  • injection needle means positioned within said sealed end chamber for passing said fluid from said end chamber through said second injectable closure means and into said evacuated space.
  • said injection needle means comprises a tubular stylus means positioned within said sealed end chamber in alignment with said second injcctable closure means and containing a first opening adjacent its leading end and a second opening through the sidewall thereof at a spaced distance therefrom. and means to advance said stylus means toward said second injectable closure means to a fully advanced position such that the leading end thereof and said first opening passes through said second injectable closure means and into said evacuated space and the second opening thereof remains in said second chamber.
  • tubular stylus depends from said cap means in alignment in said end chamber with said second injectable closure means and is advanced to its said extended position by rotating said threadably engaged cap on said second end of said centrifugation vessel.
  • thermoly sensitive gelling agent is gelatin
  • aqueous solution is an aqueous solution of a sugar.
  • aqueous solution is an aqueous solution of a macromolecular solute having microporous openings throughout its solubilized network, said openings being of sufficient size to selectively pass said pathogens from said sample fluid.
  • a method of detecting microbial pathogens in a body fluid comprising:
  • aqueous filter solution between first and second injectable zones within a centrifugation tube, said aqueous filter solution containing a thermally sensitive gelling agent and being an aqueous solution of material which is non-toxic to said microbial pathogens and has a greater density than said sample fluid but able to selectively receive microbial pathogens from said sample fluid;
  • aqueous filter solution comprises an aqueous solution of a non ionic sugar.
  • aqueous filter solution comprises an aqueous solution of a copolymer of sucrose and epichlorohydrin which has a molecular weight in the range of from about 300,000 to 500,000 and a specific rotation [01],, of 56.6.
  • aqueous filter solution comprises an aqueous solution of dextran which has a molecular weight from about l0,000 to about 2,000,000.
  • the method of claim 16 further comprises thoroughly mixing said aqueous filter solution containing said microbial pathogens; plating at least portions of said admixed, aqueous filter solution on a growth media for said microbial pathogens.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Centrifugal Separators (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
US437890A 1974-01-30 1974-01-30 Apparatus and method for the detection of microbial pathogens Expired - Lifetime US3875012A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US437890A US3875012A (en) 1974-01-30 1974-01-30 Apparatus and method for the detection of microbial pathogens
CA206,919A CA1036055A (en) 1974-01-30 1974-08-13 Apparatus and method for the detection of microbial pathogens
GB3693374A GB1475015A (en) 1974-01-30 1974-08-22 Apparatus and method for the detection of microbial pathogens
IT53444/74A IT1029614B (it) 1974-01-30 1974-10-09 Dispositivo per la rivelazione di patogeni microbici
AU75119/74A AU496227B2 (en) 1974-01-30 1974-11-07 Detection of microbial pathogens
DE2455981A DE2455981C2 (de) 1974-01-30 1974-11-27 Zentrifugierröhrchen zum Nachweis pathogener Mikroben
FR7441736A FR2264593B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-30 1974-12-18
JP50011968A JPS5812061B2 (ja) 1974-01-30 1975-01-30 病原性微生物を濃縮分離するための方法および装置

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US437890A US3875012A (en) 1974-01-30 1974-01-30 Apparatus and method for the detection of microbial pathogens

Publications (1)

Publication Number Publication Date
US3875012A true US3875012A (en) 1975-04-01

Family

ID=23738347

Family Applications (1)

Application Number Title Priority Date Filing Date
US437890A Expired - Lifetime US3875012A (en) 1974-01-30 1974-01-30 Apparatus and method for the detection of microbial pathogens

Country Status (7)

Country Link
US (1) US3875012A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5812061B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1036055A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2455981C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2264593B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1475015A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1029614B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932222A (en) * 1974-12-20 1976-01-13 J. K. & Susie L. Wadley Research Institute And Blood Bank For isolating pathogenic microorganisms
US4038150A (en) * 1976-03-24 1977-07-26 J. K. And Susie L. Wadley Research Institute And Blood Bank Sample mixing and centrifugation apparatus
DE2747496A1 (de) * 1976-11-05 1978-05-18 Wadley Res Inst & Blood Bank Verfahren und vorrichtung zur bestimmung pathogener mikroorganismen
DE2717963A1 (de) * 1977-04-21 1978-11-02 Wadley Res Inst & Blood Bank Vorrichtung zum mischen und zentrifugieren von proben
FR2400198A1 (fr) * 1977-08-11 1979-03-09 Braun Melsungen Ag Dispositif pour la determination de la vitesse de sedimentation de globules rouges du sang
US4167955A (en) * 1978-06-05 1979-09-18 Beckman Instruments, Inc. Layering a liquid sample onto centrifuge tube liquid contents
US4209488A (en) * 1978-10-10 1980-06-24 Owens-Illinois, Inc. Fluid collection apparatus
US4210623A (en) * 1978-05-01 1980-07-01 Owens-Illinois, Inc. Fluid collection apparatus
US4212948A (en) * 1978-10-18 1980-07-15 J. K. And Susie L. Wadley Research Institute And Blood Bank Apparatus for detecting microbial pathogens employing a cushioning agent
US4358425A (en) * 1981-02-17 1982-11-09 Beckman Instruments, Inc. Penetrable centrifuge tube
US4364903A (en) * 1981-04-02 1982-12-21 Becton, Dickinson And Company Contamination-free separation device
US4416984A (en) * 1981-05-22 1983-11-22 Concord Laboratories, Inc. Sterilization indicator
US4435505A (en) 1981-12-11 1984-03-06 The United States Of America As Represented By The Department Of Health And Human Services Lysis filtration culture chamber
US4515586A (en) * 1982-11-30 1985-05-07 Abbott Laboratories Powder syringe mixing system
US4519513A (en) * 1982-08-30 1985-05-28 Automatic Liquid Packaging, Inc. Container having pierceable insert
US4543328A (en) * 1978-06-16 1985-09-24 Boehringer Mannheim Gmbh Process for detecting pathogens
US4581331A (en) * 1983-09-29 1986-04-08 E. I. Du Pont De Nemours And Company Method for the rapid detection of virus and viral antigens
US4596773A (en) * 1981-05-22 1986-06-24 Concord Laboratories, Inc. Sterilization indicator
US4601704A (en) * 1983-10-27 1986-07-22 Abbott Laboratories Container mixing system with externally mounted drug container
US4606734A (en) * 1984-02-22 1986-08-19 Abbott Laboratories Container mixing system with externally mounted drug container
US4653337A (en) * 1985-03-08 1987-03-31 Metal Box P.L.C. Containers for use in detecting micro-organisms
US4666850A (en) * 1983-10-28 1987-05-19 Becton, Dickinson And Company Microbial pathogen detecting system and process
US4764473A (en) * 1983-05-13 1988-08-16 Kerforshungsanlage Julich Chamber for the treatment of cells in an electrical field
US4781679A (en) * 1986-06-12 1988-11-01 Abbott Laboratories Container system with integral second substance storing and dispensing means
US4786279A (en) * 1986-07-31 1988-11-22 Abbott Laboratories Container for mixture of materials
DE3722564A1 (de) * 1987-07-08 1989-01-19 Andreas Szabados Filtrationseinheit, insbesondere fuer medizinische proben
US4902286A (en) * 1985-11-08 1990-02-20 Claude Ranoux Container for fertilization of human ovocytes in the absence of CO2 -enriched air
US5108927A (en) * 1985-09-04 1992-04-28 Wadley Technologies, Inc. Specimen transport device containing a specimen stabilizing composition
US5135865A (en) * 1985-11-08 1992-08-04 Claude Ranoux Container for fertilization of human ovocytes in the absence of CO2 -enriched air
DE4209872A1 (de) * 1991-05-28 1992-12-03 Kratzer Michael Einrichtung zur sicheren entnahme von blut aus einem vorratsgefaess
US5178838A (en) * 1990-07-27 1993-01-12 Farmitalia Carlo Erba S. R. L. Chemical reagent vial
US5348060A (en) * 1991-08-08 1994-09-20 Nissho Corporation Drug vessel
US5427950A (en) * 1992-01-18 1995-06-27 Kabushiki Kaisha Seitai Kagaku Kankyusho Method for radioactivity measurement, process for preparing sample and device therefor
US5455176A (en) * 1994-03-14 1995-10-03 University De Montreal Microbial contamination test device
US5501960A (en) * 1993-12-03 1996-03-26 Dorn; Gordon L. Method for improving quantitative recovery of microorganisms from specimens containing blood components
US5569236A (en) * 1989-06-16 1996-10-29 Science Incorporated Fluid delivery apparatus
DE29704543U1 (de) * 1997-03-13 1997-05-07 Macherey, Nagel & Co, 52355 Düren Trenneinrichtung zur Trennung von Substanzen
US5711917A (en) * 1996-01-11 1998-01-27 Tecan U.S. Laboratory reactor apparatus
US5736355A (en) * 1996-05-13 1998-04-07 Steris Corporation Self contained biological indicator
US5743409A (en) * 1993-08-12 1998-04-28 Nikon Corporation Case for housing a substrate
US20030157564A1 (en) * 2001-12-04 2003-08-21 Dave Smith Plunger-based flow immunoassay assembly
US20040033170A1 (en) * 2000-03-22 2004-02-19 Dewalch Binz Method and apparatus for processing substances in a single container
US6976509B1 (en) * 2004-08-02 2005-12-20 Kirvan Clifford J Method and apparatus for pressurizing plastic pipe
US20060018799A1 (en) * 2004-07-21 2006-01-26 Wong Cai Ne W Universal tissue homogenizer device and methods
US20060057033A1 (en) * 2004-09-14 2006-03-16 Goldenberg Alec S Controlled additive/reactant delivery system
US20080260593A1 (en) * 2000-03-22 2008-10-23 Dewalch Norman Binz Method and apparatus for processing substances in a single container
EP1537020A4 (en) * 2002-09-03 2010-01-27 Medical Instill Tech Inc SEALED CONTAINER AND METHOD OF PRODUCTION AND FILLING
US9296498B2 (en) 2002-06-19 2016-03-29 Medinstill Development Llc Methods of filling a sealed device
CN112961763A (zh) * 2021-02-05 2021-06-15 重庆三峡学院 一种微生物定期检测用的取样装置
US11090646B2 (en) 2017-07-27 2021-08-17 Biomerieux, Inc. Isolation tube

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376634A (en) * 1980-05-30 1983-03-15 Mallinckrodt, Inc. Assay kit having syringe, dilution device and reagents within sealed container
DD206683A3 (de) * 1981-07-16 1984-02-01 Werner Schade Verfahren und vorrichtung zum nachweis von kontaminanten
DE3316335A1 (de) * 1983-05-04 1984-11-08 Fa. Andreas Hettich, 7200 Tuttlingen Verfahren zum aufsedimentieren von teilen einer probenfluessigkeit auf einen objekttraeger und vorrichtung zur ausuebung des verfahrens
DE3343887A1 (de) * 1983-12-05 1985-06-13 Walter Sarstedt Kunststoff-Spritzgußwerk, 5223 Nümbrecht Anordnung zur plazierung eines trenngels zwischen zwei in einem probenroehrchen befindlichen phasen
JP7228236B2 (ja) * 2019-03-25 2023-02-24 株式会社日立ハイテクサイエンス 遠心分離カラム及び分析対象物質の分析方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2115731A (en) * 1937-02-04 1938-05-03 Cook Lab Inc Multiple compartment ampule and hypodermic syringe
US2159217A (en) * 1937-11-05 1939-05-23 Cook Lab Inc Controllable transfer element for multiple ampules
US2193322A (en) * 1938-04-30 1940-03-12 Cook Lab Inc Controllable transfer element for multiple compartment ampules
US2590900A (en) * 1949-03-23 1952-04-01 Sommerstein Cwi Ampoule
US3072538A (en) * 1960-12-30 1963-01-08 Grace W R & Co Isolation of bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780935A (en) * 1972-07-10 1973-12-25 Lukacs & Jacoby Ass Serum separating method
US3928139A (en) * 1973-02-12 1975-12-23 Wadley Res Inst & Blood Bank Detection of microbial pathogens
JPS5351189A (en) * 1976-10-21 1978-05-10 Terumo Corp Composite for liquid separation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2115731A (en) * 1937-02-04 1938-05-03 Cook Lab Inc Multiple compartment ampule and hypodermic syringe
US2159217A (en) * 1937-11-05 1939-05-23 Cook Lab Inc Controllable transfer element for multiple ampules
US2193322A (en) * 1938-04-30 1940-03-12 Cook Lab Inc Controllable transfer element for multiple compartment ampules
US2590900A (en) * 1949-03-23 1952-04-01 Sommerstein Cwi Ampoule
US3072538A (en) * 1960-12-30 1963-01-08 Grace W R & Co Isolation of bacteria

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932222A (en) * 1974-12-20 1976-01-13 J. K. & Susie L. Wadley Research Institute And Blood Bank For isolating pathogenic microorganisms
FR2294745A1 (fr) * 1974-12-20 1976-07-16 Wadley Res Inst & Blood Bank Dispositif de melange et de centrifugation
US4038150A (en) * 1976-03-24 1977-07-26 J. K. And Susie L. Wadley Research Institute And Blood Bank Sample mixing and centrifugation apparatus
DE2747496A1 (de) * 1976-11-05 1978-05-18 Wadley Res Inst & Blood Bank Verfahren und vorrichtung zur bestimmung pathogener mikroorganismen
FR2393063A1 (fr) * 1976-11-05 1978-12-29 Wadley Res Inst & Blood Bank Procede de determination de microorganismes pathogenes
DE2717963A1 (de) * 1977-04-21 1978-11-02 Wadley Res Inst & Blood Bank Vorrichtung zum mischen und zentrifugieren von proben
FR2400198A1 (fr) * 1977-08-11 1979-03-09 Braun Melsungen Ag Dispositif pour la determination de la vitesse de sedimentation de globules rouges du sang
US4210623A (en) * 1978-05-01 1980-07-01 Owens-Illinois, Inc. Fluid collection apparatus
US4167955A (en) * 1978-06-05 1979-09-18 Beckman Instruments, Inc. Layering a liquid sample onto centrifuge tube liquid contents
US4543328A (en) * 1978-06-16 1985-09-24 Boehringer Mannheim Gmbh Process for detecting pathogens
US4209488A (en) * 1978-10-10 1980-06-24 Owens-Illinois, Inc. Fluid collection apparatus
US4212948A (en) * 1978-10-18 1980-07-15 J. K. And Susie L. Wadley Research Institute And Blood Bank Apparatus for detecting microbial pathogens employing a cushioning agent
US4358425A (en) * 1981-02-17 1982-11-09 Beckman Instruments, Inc. Penetrable centrifuge tube
US4364903A (en) * 1981-04-02 1982-12-21 Becton, Dickinson And Company Contamination-free separation device
US4416984A (en) * 1981-05-22 1983-11-22 Concord Laboratories, Inc. Sterilization indicator
US4596773A (en) * 1981-05-22 1986-06-24 Concord Laboratories, Inc. Sterilization indicator
US4435505A (en) 1981-12-11 1984-03-06 The United States Of America As Represented By The Department Of Health And Human Services Lysis filtration culture chamber
US4519513A (en) * 1982-08-30 1985-05-28 Automatic Liquid Packaging, Inc. Container having pierceable insert
US4515586A (en) * 1982-11-30 1985-05-07 Abbott Laboratories Powder syringe mixing system
US4764473A (en) * 1983-05-13 1988-08-16 Kerforshungsanlage Julich Chamber for the treatment of cells in an electrical field
US4581331A (en) * 1983-09-29 1986-04-08 E. I. Du Pont De Nemours And Company Method for the rapid detection of virus and viral antigens
US4601704A (en) * 1983-10-27 1986-07-22 Abbott Laboratories Container mixing system with externally mounted drug container
US4666850A (en) * 1983-10-28 1987-05-19 Becton, Dickinson And Company Microbial pathogen detecting system and process
US4606734A (en) * 1984-02-22 1986-08-19 Abbott Laboratories Container mixing system with externally mounted drug container
US4653337A (en) * 1985-03-08 1987-03-31 Metal Box P.L.C. Containers for use in detecting micro-organisms
US5108927A (en) * 1985-09-04 1992-04-28 Wadley Technologies, Inc. Specimen transport device containing a specimen stabilizing composition
US5135865A (en) * 1985-11-08 1992-08-04 Claude Ranoux Container for fertilization of human ovocytes in the absence of CO2 -enriched air
US4902286A (en) * 1985-11-08 1990-02-20 Claude Ranoux Container for fertilization of human ovocytes in the absence of CO2 -enriched air
US4781679A (en) * 1986-06-12 1988-11-01 Abbott Laboratories Container system with integral second substance storing and dispensing means
US4786279A (en) * 1986-07-31 1988-11-22 Abbott Laboratories Container for mixture of materials
DE3722564A1 (de) * 1987-07-08 1989-01-19 Andreas Szabados Filtrationseinheit, insbesondere fuer medizinische proben
US5569236A (en) * 1989-06-16 1996-10-29 Science Incorporated Fluid delivery apparatus
US5178838A (en) * 1990-07-27 1993-01-12 Farmitalia Carlo Erba S. R. L. Chemical reagent vial
DE4209872A1 (de) * 1991-05-28 1992-12-03 Kratzer Michael Einrichtung zur sicheren entnahme von blut aus einem vorratsgefaess
US5348060A (en) * 1991-08-08 1994-09-20 Nissho Corporation Drug vessel
US5427950A (en) * 1992-01-18 1995-06-27 Kabushiki Kaisha Seitai Kagaku Kankyusho Method for radioactivity measurement, process for preparing sample and device therefor
US5743409A (en) * 1993-08-12 1998-04-28 Nikon Corporation Case for housing a substrate
US5501960A (en) * 1993-12-03 1996-03-26 Dorn; Gordon L. Method for improving quantitative recovery of microorganisms from specimens containing blood components
US5455176A (en) * 1994-03-14 1995-10-03 University De Montreal Microbial contamination test device
US5711917A (en) * 1996-01-11 1998-01-27 Tecan U.S. Laboratory reactor apparatus
US5736355A (en) * 1996-05-13 1998-04-07 Steris Corporation Self contained biological indicator
DE29704543U1 (de) * 1997-03-13 1997-05-07 Macherey, Nagel & Co, 52355 Düren Trenneinrichtung zur Trennung von Substanzen
US9637251B2 (en) 2000-02-11 2017-05-02 Medinstill Development Llc Sealed containers and methods of filling and resealing same
US9051064B2 (en) 2000-02-11 2015-06-09 Medinstill Development Llc Resealable containers and methods of making, filling and resealing same
US20100236659A1 (en) * 2000-02-11 2010-09-23 Daniel Py Resealable Containers and Methods of Making, Filling and Resealing Same
US8960242B2 (en) * 2000-02-11 2015-02-24 Medinstill Development Llc Sealed containers and methods of filling and resealing same
US20110277873A1 (en) * 2000-02-11 2011-11-17 Py Daniel C Sealed Containers and Methods of Filling and Resealing Same
US20040033170A1 (en) * 2000-03-22 2004-02-19 Dewalch Binz Method and apparatus for processing substances in a single container
US20110044866A1 (en) * 2000-03-22 2011-02-24 Dewalch Norman Binz Method and Apparatus for Processing Substances in a Single Container
US20080260593A1 (en) * 2000-03-22 2008-10-23 Dewalch Norman Binz Method and apparatus for processing substances in a single container
US20030166264A1 (en) * 2001-12-04 2003-09-04 Dave Smith Drug and alcohol assay assembly
US20030157480A1 (en) * 2001-12-04 2003-08-21 Dave Smith Flow immunoassay scanning assembly
US20030157564A1 (en) * 2001-12-04 2003-08-21 Dave Smith Plunger-based flow immunoassay assembly
US9296498B2 (en) 2002-06-19 2016-03-29 Medinstill Development Llc Methods of filling a sealed device
EP1537020A4 (en) * 2002-09-03 2010-01-27 Medical Instill Tech Inc SEALED CONTAINER AND METHOD OF PRODUCTION AND FILLING
US20060018799A1 (en) * 2004-07-21 2006-01-26 Wong Cai Ne W Universal tissue homogenizer device and methods
US6976509B1 (en) * 2004-08-02 2005-12-20 Kirvan Clifford J Method and apparatus for pressurizing plastic pipe
US7700046B2 (en) * 2004-09-14 2010-04-20 Goldenberg Alec S Controlled additive/reactant delivery system
US20060057033A1 (en) * 2004-09-14 2006-03-16 Goldenberg Alec S Controlled additive/reactant delivery system
US11305273B2 (en) 2017-07-27 2022-04-19 Biomerieux, Inc. Isolation tube with a rheological control member and a plunger
US11090646B2 (en) 2017-07-27 2021-08-17 Biomerieux, Inc. Isolation tube
US11325117B2 (en) * 2017-07-27 2022-05-10 Biomerieux, Inc. Centrifugally separating samples in a container having a seal and containing a plunger for opening the seal
US11383231B2 (en) 2017-07-27 2022-07-12 Biomerieux, Inc. Isolation tube
US11440000B2 (en) * 2017-07-27 2022-09-13 Biomerieux, Inc. Isolation tube with an endcap
US11850584B2 (en) 2017-07-27 2023-12-26 Biomerieux, Inc. Isolation tube
US11883818B2 (en) 2017-07-27 2024-01-30 Biomerieux, Inc. Isolation tube
US11918998B2 (en) 2017-07-27 2024-03-05 BIOMéRIEUX, INC. Assembly comprising a sample collection vessel and a separation container having seal, plunger with seal-piercing point, retainer, and flexible sealing member
US12070745B2 (en) 2017-07-27 2024-08-27 Biomerieux, Inc. Isolation tube woth and endcap
US12220695B2 (en) 2017-07-27 2025-02-11 Biomerieux, Inc. Isolation tube
CN112961763A (zh) * 2021-02-05 2021-06-15 重庆三峡学院 一种微生物定期检测用的取样装置
CN112961763B (zh) * 2021-02-05 2024-01-09 重庆三峡学院 一种微生物定期检测用的取样装置

Also Published As

Publication number Publication date
CA1036055A (en) 1978-08-08
GB1475015A (en) 1977-06-01
DE2455981C2 (de) 1986-10-23
AU7511974A (en) 1976-05-13
FR2264593B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-02-06
JPS51105891A (en) 1976-09-20
JPS5812061B2 (ja) 1983-03-05
FR2264593A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-17
DE2455981A1 (de) 1975-07-31
IT1029614B (it) 1979-03-20

Similar Documents

Publication Publication Date Title
US3875012A (en) Apparatus and method for the detection of microbial pathogens
US3932222A (en) For isolating pathogenic microorganisms
US3928139A (en) Detection of microbial pathogens
US4038150A (en) Sample mixing and centrifugation apparatus
US4164449A (en) Surface separation technique for the detection of microbial pathogens
US4212948A (en) Apparatus for detecting microbial pathogens employing a cushioning agent
CA1098429A (en) Method for detecting microbial pathogens employing a cushioning agent
CA2501196A1 (en) Sample collection system with caspase inhibitor
Clawson et al. Platelet interaction with bacteria: II. Fate of the bacteria
US7309468B2 (en) Protease inhibitor sample collection system
Castaneda Laboratory diagnosis of brucellosis in man
Melsom et al. The cytotoxic effect of mouse macrophages on syngeneic and allogeneic erythrocytes
JPS5888324A (ja) 生体外において細胞又は組織を培養する培養方法
US6027938A (en) Micropathological patient replica based on unadulterated whole blood
US5550060A (en) Method and procedure for preparing red blood fractions
CA1248435A (en) Process and device for the detection of pathogens
Segel et al. Plateletpheresis residues: a source of large quantities of human blood lymphocytes
Tullis Studies on permeability of the leucocyte
CH615511A5 (en) Device for mixing a dose of sample fluid with a treatment liquid
Wall et al. An evaluation of the preservation of human blood stored in experimental plastic containers: I. In vitro studies
Denstedt et al. Problems in the Preservation of Blood
de Wit et al. A dextran agglomeration method for the preparation in a closed plastic bag system of leucocyte poor blood for transfusion
EP0789072A2 (en) Growth environment assembly and method of use therof
Andersen et al. Acryl fibres for the isolation of human lymphocytes
Isogai et al. Platelet size, shape and filterability